
CytoDyn, Inc. (OTC: CYDY)
Next Super Stock investor conference presentation 8/15/2019
Pulmatrix (NASDAQ: PULM) Investor Presentation 9/5/2018 Did you enjoy this article? Join our FREE Newsletter! I agree to have my personal information transfered to MailChimp ( more information ) Join over 100,000 investors and business […]
VANCOUVER, Washington, Sep 06, 2019 — CytoDyn Inc. (otc.qb:CYDY), (“CytoDyn” or the “Company”), a late stage biotechnology company developing leronlimab (PRO 140), a CCR5 antagonist with the potential for multiple therapeutic indications, announced today that […]
VANCOUVER, Washington, Feb. 27, 2019 — CytoDyn Inc. (OTC.QB: CYDY), a late stage biotechnology company developing a novel humanized CCR5 monoclonal antibody for multiple therapeutic indications, today announced that data from its study of leronlimab […]
Copyright 1997-2019 Wall Street Reporter / Octagon Media Corp.